|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
Q1 FY2011
As of Mar 31, 2011
|
Q4 FY2010
As of Dec 31, 2010
|
Q3 FY2010
As of Sep 30, 2010
|
Q2 FY2010
As of Jun 30, 2010
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||
| Current assets: | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Short-term investments | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Inventory | ||||||||||||||||||
| Deferred tax assets, net | ||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||
| Total current assets | ||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||
| In-process research and development | ||||||||||||||||||
| Goodwill | ||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Long-term investments | ||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||
| Current liabilities: | ||||||||||||||||||
| Accounts payable | ||||||||||||||||||
| Accrued liabilities | ||||||||||||||||||
| Short-term deferred revenue | ||||||||||||||||||
| Short-term contingent consideration | ||||||||||||||||||
| Other current liabilities | ||||||||||||||||||
| Total current liabilities | ||||||||||||||||||
| Short-term debt, net | ||||||||||||||||||
| Long-term deferred revenue | ||||||||||||||||||
| Long-term deferred tax liabilities, net | ||||||||||||||||||
| Long-term contingent consideration | ||||||||||||||||||
| Long-term debt, net | ||||||||||||||||||
| Other long-term liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||
| Preferred stock, non-cumulative; convertible, $.001 par value; authorized 5,000,000 shares; no shares issued and outstanding | ||||||||||||||||||
| Common stock, $.001 par value; authorized 300,000,000 shares; 76,012,863 and 74,428,087 shares issued and outstanding as of September 30, 2014 and December 31, 2013, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive (loss) income | ||||||||||||||||||
| Retained earnings | ||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||
Loading...
